Skip To Main Content
Constantine Frangakis on Muck Rack

Constantine Frangakis

As seen in: JAMA: Journal of the American Medical Association, Journal of Interventional Radiology (JVIR)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Constantine Frangakis’s profile

Articles by Constantine Frangakis

Computerized Tomography Guided Celiac Ganglion Block for Neurogenic Gastrointestinal Dysmotility

|
By Constantine Frangakis, Beatriz Kohler, Christos S. Georgiades
| Journal of Interventional Radiology (JVIR) Verified
Purpose To determine whether celiac ganglion block can serve as a diagnostic test for dysautonomia as the cause of gastrointestinal dysmotility symptoms. Methods This was an Institutional Review Board-approved, prospective, single-arm, registered study, from 1/2020-5/2021. It included patients aged 14-85 with gastrointestinal symptoms of food intolerance, abdominal pain or angina.
Open in Who Shared Issue with article?

Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma with Intra-atrial Tumor Extension: Imaging Response and Oncologic Outcomes

|
By Andrew Kolarich, Constantine Frangakis, Mark Yarchoan, Kelvin Hong
| Journal of Interventional Radiology (JVIR) Verified
Abstract To evaluate outcomes in patients with right atrial (RA) hepatocellular carcinoma extension treated with transarterial chemoembolization. Eight patients were retrospectively reviewed. Follow-up visits occurred at 4–6 weeks; transarterial chemoembolization was repeated if residual tumor persisted. After transarterial chemoembolization, RA tumor volume reduction was 86% ± 19; α-fetoprotein level showed a reduction of 95%.
Open in Who Shared Issue with article?

Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial

|
By Anton Porsteinsson, Bruce G Pollock, D. P. Devanand, Constantine Frangakis
| JAMA: Journal of the American Medical Association Verified
Abstract Importance Agitation is common, persistent, and associated with adverse consequences for patients with Alzheimer disease. Pharmacological treatment options, including antipsychotics are not satisfactory. Objective The primary objective was to evaluate the efficacy of citalopram for agitation in patients with Alzheimer disease. Key secondary objectives examined effects of citalopram on function, caregiver distress, safety, cognitive safety, and tolerability.
Open in Who Shared Issue with article?
Show More